0
Il n'y a pas de produit dans le panier !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > Integrin alpha V beta 6

Integrin alpha V beta 6

Brief Information

Name:Integrin alpha-V/beta-6
Target Synonym:
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:6
Lastest Research Phase:Phase 3 Clinical

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data

CHEK-ATP125-Cell-based assay
 Integrin alpha V beta 6 FACS

Expression analysis of human Integrin alpha V on HEK293/Human Integrin alpha V beta 6 Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human Integrin alpha V beta 6 Stable Cell Line or negative control cell using anti-human Integrin alpha V antibody followed by staining with FITC anti-mouse IgG Antibody.

CHEK-ATP125-Cell-based assay
 Integrin alpha V beta 6 FACS

Expression analysis of human Integrin beta 6 on HEK293/Human Integrin alpha V beta 6 Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human Integrin alpha V beta 6 Stable Cell Line or negative control cell using anti-human Integrin beta 6 antibody followed by staining with PE anti-human IgG Fc Antibody.

IT6-C52W9-SPR
 Integrin alpha V beta 6 SPR

Fibronectin fragment, premium grade (Cat. No. FIN-H5113) immobilized on CM5 Chip can bind Cynomolgus ITGAV&ITGB6 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT6-C52W9) with an affinity constant of 0.946 µM as determined in a SPR assay (Biacore 8K) (Routinely tested).

IT6-H52E1-SPR
 Integrin alpha V beta 6 SPR

Fibronectin fragment, premium grade (Cat. No. FIN-H5113) immobilized on CM5 Chip can bind Human ITGAV&ITGB6 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT6-H52E1) with an affinity constant of 1.23 µM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Customer Reviews

Synonym Name

Integrin alpha V beta 6,ITGAV&ITGB6

Background

Integrin alpha V beta 6 is a heterodimer of beta-6 associating with alpha-V. Integrin alpha-V beta-6 is a receptor for fibronectin and cytotactin. It recognizes the sequence R-G-D in its ligands. Internalisation of integrin alpha-V beta-6 via clathrin-mediated endocytosis promotes carcinoma cell invasion. Also, Integrin alpha-V beta-6 acts as a receptor for coxsackievirus A9 and coxsackievirus B1 as well as herpes simplex virus-1/HHV-1. Furthermore, it binds the TGF-beta latency‑associated peptide (LAP) and activates TGF-beta 1 or TGF-beta 3 from large latent complexes. This activation requires interaction with LTBP-1 and fibronectin, and is enhanced by PAR-1.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Bexotegrast PLN-74809 Phase 3 Clinical Pliant Therapeutics Inc Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Cholangitis, Sclerosing Details
IDL-2965 IDL-2965 Phase 2 Clinical Indalo Therapeutics Inc Metabolic Dysfunction-Associated Steatotic Liver Disease; Idiopathic Pulmonary Fibrosis Details
Nesvategrast OTT-166(OcuTerra Therapeutics); SF-0166 Phase 2 Clinical Scifluor Life Sciences Inc, OcuTerra Therapeutics Inc Diabetic macular oedema; Diabetic Retinopathy; Macular Degeneration Details
18F-αvβ6-Binding-Peptide 18F-αvβ6-BP Phase 1 Clinical National Cancer Institute, National Institutes Of Health Rectal Neoplasms; Colonic Neoplasms; Coronavirus Disease 2019 (COVID-19); Pancreatic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Coronaviridae Infections; Lung Neoplasms; Metastatic breast cancer Details
[18F]FP-R01-MG [18F]FP-R01-MG; [18F]FP-R01-MG-F2 Phase 1 Clinical Pliant Therapeutics Inc, Stanford University, Chinese Academy Of Medical Science & Peking Union Medical College Small Cell Lung Carcinoma; Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Pancreatic Neoplasms; Cholangitis, Sclerosing; Brain metastases; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Ga-68-Trivehexin RAD-301 Phase 1 Clinical Trimt GmbH Pancreatic Neoplasms; Carcinoma, Pancreatic Ductal Details
Bexotegrast PLN-74809 Phase 3 Clinical Pliant Therapeutics Inc Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Cholangitis, Sclerosing Details
IDL-2965 IDL-2965 Phase 2 Clinical Indalo Therapeutics Inc Metabolic Dysfunction-Associated Steatotic Liver Disease; Idiopathic Pulmonary Fibrosis Details
Nesvategrast OTT-166(OcuTerra Therapeutics); SF-0166 Phase 2 Clinical Scifluor Life Sciences Inc, OcuTerra Therapeutics Inc Diabetic macular oedema; Diabetic Retinopathy; Macular Degeneration Details
18F-αvβ6-Binding-Peptide 18F-αvβ6-BP Phase 1 Clinical National Cancer Institute, National Institutes Of Health Rectal Neoplasms; Colonic Neoplasms; Coronavirus Disease 2019 (COVID-19); Pancreatic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Coronaviridae Infections; Lung Neoplasms; Metastatic breast cancer Details
[18F]FP-R01-MG [18F]FP-R01-MG; [18F]FP-R01-MG-F2 Phase 1 Clinical Pliant Therapeutics Inc, Stanford University, Chinese Academy Of Medical Science & Peking Union Medical College Small Cell Lung Carcinoma; Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Pancreatic Neoplasms; Cholangitis, Sclerosing; Brain metastases; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Ga-68-Trivehexin RAD-301 Phase 1 Clinical Trimt GmbH Pancreatic Neoplasms; Carcinoma, Pancreatic Ductal Details

This web search service is supported by Google Inc.

totop

Laisser un message